{"id":"NCT01844518","sponsor":"Bristol-Myers Squibb","briefTitle":"Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)","officialTitle":"A Phase 3 Multi-center, Open-Label Study to Evaluate Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-08-30","primaryCompletion":"2015-03-12","completion":"2023-02-01","firstPosted":"2013-05-01","resultsPosted":"2016-03-24","lastUpdate":"2023-07-12"},"enrollment":219,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Active Polyarticular Juvenile Idiopathic Arthritis"],"interventions":[{"type":"BIOLOGICAL","name":"Abatacept","otherNames":["Orencia"]}],"arms":[{"label":"Short and Long Terms: Orencia","type":"EXPERIMENTAL"}],"summary":"The purpose of this study is to estimate Abatacept steady-state trough concentration (Cmin) at Day 113 in children and adolescents with pJIA","primaryOutcome":{"measure":"Abatacept Trough Concentration (Cmin) in Participants Ages 6 to 17","timeFrame":"Day 113","effectByArm":[{"arm":"SC Abatacept Ages 6 to 17","deltaMin":39.7,"sd":35}],"pValues":[]},"eligibility":{"minAge":"2 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":3},"locations":{"siteCount":57,"countries":["United States","Argentina","Belgium","Brazil","France","Germany","Italy","Mexico","Peru","Russia","South Africa","Spain"]},"refs":{"pmids":["37453737","37221146","36710243","33452173","32087715","29481737"],"seeAlso":["https://www.bms.com/researchers-and-partners/clinical-trials-and-research.html","http://www.BMSStudyConnect.com"]},"adverseEventsSummary":{"seriousAny":{"events":18,"n":173},"commonTop":["Nasopharyngitis","Upper respiratory tract infection","Pyrexia","Headache","Nausea"]}}